Table 1 Clinicopathological characteristics for the 206 ovarian carcinoma patients
Number of patients (%) | |||||
|---|---|---|---|---|---|
HGSC | EC | MC | CCC | ||
(n = 94) | (n = 46) | (n = 29) | (n = 37) | P value | |
Patient age | 0.457 | ||||
Mean | 64 | 62 | 60 | 65 | |
Range | 22–88 | 25–83 | 30–82 | 42–84 | |
Overall Survival | 0.082 | ||||
0-2y | 7 (7) | 3 (7) | 6 (21) | 5 (14) | |
2-5y | 26 (28) | 9 (20) | 3 (10) | 10 (27) | |
5-10y | 28 (30) | 7 (15) | 7 (24) | 8 (22) | |
>10y | 33 (35) | 27 (59) | 13 (45) | 14 (38) | |
Cause of death | 0.001 | ||||
Ovarian carcinoma | 53 (56) | 7 (15) | 5 (17) | 19 (51) | |
Other cancer | 8 (9) | 6 (13) | 4 (14) | 2 (5) | |
Other | 10 (11) | 10 (22) | 8 (28) | 6 (16) | |
Alive | 15 (16) | 17 (37) | 7 (24) | 8 (22) | |
Not available | 8 (9) | 6 (13) | 5 (17) | 2 (5) | |
Stage | 0.005 | ||||
I | 51 (54) | 32 (70) | 22 (76) | 31 (84) | |
II | 43 (46) | 13 (28) | 7 (24) | 6 (16) | |
Tumor grade EC | NA | ||||
FIGO grade I | NA | 11 (24) | NA | NA | |
FIGO grade II | NA | 27 (59) | NA | NA | |
FIGO grade III | NA | 8 (17) | NA | NA | |
Dualistic model | 0.643 | ||||
Type I | 0 (0) | 46 (100) | 29 (100) | 37 (100) | |
Type II | 94(100) | 0 (0) | 0 (0) | 0 (0) | |
CA125 | 0.106 | ||||
<35 | 17 (18) | 13 (28) | 10 (35) | 14 (38) | |
35–65 | 17 (18) | 7 (15) | 8 (28) | 8 (22) | |
>65 | 60 (64) | 25 (54) | 11 (38) | 15 (41) | |
Not available | 0 (0) | 1 (2) | 0 (0) | 0 (0) | |
Ploidy | 0.168 | ||||
Near diploid | 22 (23) | 17 (37) | 7 (24) | 5 (14) | |
Aneuploid | 69 (73) | 26 (57) | 19 (66) | 30 (81) | |
Not available | 3 (3) | 3 (7) | 3 (10) | 2 (5) | |
Chemotherapy | 0.212 | ||||
Yes | 91 (97) | 42 (91) | 27 (93) | 37 (100) | |
No | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
Not available | 3 (3) | 4(9) | 2 (7) | 0 (0) | |